论文部分内容阅读
目的探讨经尿道双极等离子电切术治疗前列腺癌的临床疗效及生活质量。方法选取2009年7月至2015年7月间收治的80例前列腺癌患者,按照手术类型分为观察组和对照组,每组40例。观察组患者采用经尿道等离子电切术,对照组患者采用经尿道前列腺电切术,对比两组患者国际前列腺癌症状评分(IPSS)、最大尿流率、残余尿量、血清前列腺特异抗原(PSA)、尿管拔除时间、手术时间、术中出血量和生活质量。结果与治疗前比较,两组患者治疗后IPSS评分降低,最大尿流率增高,残余尿量减少,血清PSA水平降低,差异均有统计学意义(均P<0.05)。两组患者治疗后IPSS评分、最大尿流率、残余尿量和血清PSA水平的差异均无统计学意义(均P>0.05)。与对照组比较,观察组患者尿管拔出时间缩短,术中出血量较少,差异均有统计学意义(均P<0.05)。两组患者的手术时间比较,差异无统计学意义(P>0.05)。两组患者的躯体功能、角色功能、认知功能、情绪功能和社区功能评分差异均无统计学意义(均P>0.05)。结论经尿道双极等离子电切术治疗前列腺癌的临床疗效显著,与经尿道前列腺电切术无明显差异,但缩短了尿管拔出时间,并减少了术中出血量,可有效地缓解因前列腺癌造成的尿道梗阻症状,改善患者的生活质量。
Objective To investigate the clinical efficacy and quality of life of transurethral bipolar plasmatomy for the treatment of prostate cancer. Methods Eighty patients with prostate cancer who were treated between July 2009 and July 2015 were selected and divided into observation group and control group according to the type of operation, 40 cases in each group. The patients in the observation group were treated by transurethral resection of the plasma and the patients in the control group were treated with transurethral resection of the prostate. The scores of IPSS, maximum urinary flow, residual urine volume, serum PSA ), Catheter removal time, operation time, intraoperative blood loss and quality of life. Results Compared with those before treatment, IPSS score, maximal uroflow rate, residual urine volume and serum PSA decreased in both groups after treatment (both P <0.05). There was no significant difference in IPSS score, maximum flow rate, residual urine volume and serum PSA between the two groups after treatment (all P> 0.05). Compared with the control group, the observation group patients with shorter catheter pullout time, less blood loss, the differences were statistically significant (P <0.05). There was no significant difference in operative time between the two groups (P> 0.05). There was no significant difference in somatic, role, cognitive, emotional and community function scores between the two groups (all P> 0.05). Conclusions The clinical efficacy of transurethral bipolar plasmakinectomy in the treatment of prostate cancer is significant. There is no significant difference between transurethral resection and transurethral resection of prostate, but it can shorten the time of catheter extraction and reduce the intraoperative blood loss, which can effectively alleviate the risk of prostate cancer Urinary tract obstruction caused by prostate cancer symptoms, improve the quality of life of patients.